These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33410644)

  • 1. Dr. Patrick Kochanek: A "Wild Ride" Olé!… 20 Years of Editorial Genius, Drive, and Vision.
    Nadkarni V; Kissoon N
    Pediatr Crit Care Med; 2021 Jan; 22(1):5-7. PubMed ID: 33410644
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of less aggressive treatment on diabetic retinopathy severity scale scores: analyses of the RIDE and RISE open-label extension.
    Goldberg RA; Hill L; Davis T; Stoilov I
    BMJ Open Ophthalmol; 2022 Jul; 7(1):. PubMed ID: 36161830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-Label Extension of RIDE and RISE Studies.
    Sun JK; Wang PW; Taylor S; Haskova Z
    Ophthalmology; 2019 May; 126(5):712-720. PubMed ID: 30419298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials.
    Wykoff CC; Elman MJ; Regillo CD; Ding B; Lu N; Stoilov I
    Ophthalmology; 2016 Aug; 123(8):1716-1721. PubMed ID: 27208982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing a new editor for Pediatric Critical Care Medicine: Patrick M. Kochanek, MD.
    Parrillo JE
    Pediatr Crit Care Med; 2001 Apr; 2(2):105. PubMed ID: 12813250
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema: Report From RESTORE, RIDE, and RISE Trials.
    Bressler NM; Varma R; Mitchell P; Suñer IJ; Dolan C; Ward J; Ferreira A; Ehrlich JS; Turpcu A
    JAMA Ophthalmol; 2016 Feb; 134(2):160-6. PubMed ID: 26584450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials.
    Singer M; Liu M; Schlottmann PG; Khanani AM; Hemphill M; Hill L; Tuomi L; Haskova Z
    Clin Ophthalmol; 2020; 14():1629-1639. PubMed ID: 32606578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dr Andreas Gruentzig--more than 30 years of the genius vision in therapy of coronary artery disease].
    Zdravković M; Krotin M; Zdravković D; Radovanović S
    Vojnosanit Pregl; 2012 Jun; 69(6):541-4. PubMed ID: 22779303
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials.
    Boyer DS; Nguyen QD; Brown DM; Basu K; Ehrlich JS;
    Ophthalmology; 2015 Dec; 122(12):2504-13.e1. PubMed ID: 26452713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).
    Sheetz MJ; Aiello LP; Shahri N; Davis MD; Kles KA; Danis RP;
    Retina; 2011 Jun; 31(6):1053-9. PubMed ID: 21386766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course of Diabetic Retinopathy in Untreated Fellow Eyes in RIDE and RISE: A Post Hoc Analysis.
    Bakri SJ; Malhotra M; Stoilov I
    Ophthalmic Surg Lasers Imaging Retina; 2022 Apr; 53(4):202-207. PubMed ID: 35417296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic restrictions in olive pollen allergy.
    Cardaba B; Cortegano I; Florido F; Arrieta I; Aceituno E; del Pozo V; Gallardo S; Rojo M; Palomino P; Lahoz C
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):292-8. PubMed ID: 10669850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleuropein promotes hippocampal LTP via intracellular calcium mobilization and Ca
    Wang M; Ramasamy VS; Kang HK; Jo J
    Neuropharmacology; 2020 Oct; 176():108196. PubMed ID: 32598912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides.
    Malliou F; Andreadou I; Gonzalez FJ; Lazou A; Xepapadaki E; Vallianou I; Lambrinidis G; Mikros E; Marselos M; Skaltsounis AL; Konstandi M
    J Nutr Biochem; 2018 Sep; 59():17-28. PubMed ID: 29960113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second RNA-binding protein is essential for ethanol tolerance provided by the bacterial OLE ribonucleoprotein complex.
    Harris KA; Zhou Z; Peters ML; Wilkins SG; Breaker RR
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6319-E6328. PubMed ID: 29915070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Robert Schumann's mental illnesses. (Genius and madness)', by Mlle Dr Pascal (1908a): Introduction and translation by Felicia Gordon.
    Gordon F
    Hist Psychiatry; 2015 Sep; 26(3):359-71. PubMed ID: 26254133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driving self-regulation and ride service utilization in a multicommunity, multistate sample of U.S. older adults.
    Bird DC; Freund K; Fortinsky RH; Staplin L; West BA; Bergen G; Downs J
    Traffic Inj Prev; 2017 Apr; 18(3):267-272. PubMed ID: 27574778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and biochemical characterization of the OLE-1 high-oleic castor seed (Ricinus communis L.) mutant.
    Venegas-Calerón M; Sánchez R; Salas JJ; Garcés R; Martínez-Force E
    Planta; 2016 Jul; 244(1):245-58. PubMed ID: 27056057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Outcomes of the Ole e 1 Proteins Involved in Pollen Tube Development: Impact on Allergies.
    Fernández-González M; González-Fernández E; Fernández-González D; Rodríguez-Rajo FJ
    Front Plant Sci; 2020; 11():974. PubMed ID: 32719701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Does Ride-Hailing Influence Individual Mode Choice? An Examination Using Longitudinal Trip Data from the Seattle Region.
    Wang Y; Moudon AV; Shen Q
    Transp Res Rec; 2022 Mar; 2676(3):621-633. PubMed ID: 35694240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.